Comprehensive investigation of sources of misclassification errors in routine HIV testing in Zimbabwe.
Adult
Diagnostic Tests, Routine
Female
HIV Infections
/ diagnosis
HIV Testing
/ standards
Humans
Infectious Disease Transmission, Vertical
/ prevention & control
Male
Mass Screening
/ methods
Pregnancy
Pregnancy Complications, Infectious
/ diagnosis
Reproducibility of Results
Sensitivity and Specificity
Zimbabwe
/ epidemiology
HIV testing
Zimbabwe
false-HIV-negative results
false-HIV-positive results
misclassification errors
rapid diagnostic tests
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
26
02
2021
received:
02
11
2020
accepted:
10
03
2021
entrez:
21
4
2021
pubmed:
22
4
2021
medline:
18
9
2021
Statut:
ppublish
Résumé
Misclassification errors have been reported in rapid diagnostic HIV tests (RDTs) in sub-Saharan African countries. These errors can lead to missed opportunities for prevention-of-mother-to-child-transmission (PMTCT), early infant diagnosis and adult HIV-prevention, unnecessary lifelong antiretroviral treatment (ART) and wasted resources. Few national estimates or systematic quantifications of sources of errors have been produced. We conducted a comprehensive assessment of possible sources of misclassification errors in routine HIV testing in Zimbabwe. RDT-based HIV test results were extracted from routine PMTCT programme records at 62 sites during national antenatal HIV surveillance in 2017. Positive- (PPA) and negative-percent agreement (NPA) for HIV RDT results and the false-HIV-positivity rate for people with previous HIV-positive results ("known-positives") were calculated using results from external quality assurance testing done for HIV surveillance purposes. Data on indicators of quality management systems, RDT kit performance under local climatic conditions and user/clerical errors were collected using HIV surveillance forms, data-loggers and a Smartphone camera application (7 sites). Proportions of cases with errors were compared for tests done in the presence/absence of potential sources of errors. NPA was 99.9% for both pregnant women (N = 17224) and male partners (N = 2173). PPA was 90.0% (N = 1187) and 93.4% (N = 136) for women and men respectively. 3.5% (N = 1921) of known-positive individuals on ART were HIV negative. Humidity and temperature exceeding manufacturers' recommendations, particularly in storerooms (88.6% and 97.3% respectively), and premature readings of RDT output (56.0%) were common. False-HIV-negative cases, including interpretation errors, occurred despite staff training and good algorithm compliance, and were not reduced by existing external or internal quality assurance procedures. PPA was lower when testing room humidity exceeded 60% (88.0% vs. 93.3%; p = 0.007). False-HIV-negative results were still common in Zimbabwe in 2017 and could be reduced with HIV testing algorithms that use RDTs with higher sensitivity under real-world conditions and greater practicality under busy clinic conditions, and by strengthening proficiency testing procedures in external quality assurance systems. New false-HIV-positive RDT results were infrequent but earlier errors in testing may have resulted in large numbers of uninfected individuals being on ART.
Identifiants
pubmed: 33882190
doi: 10.1002/jia2.25700
pmc: PMC8059712
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25700Subventions
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
Références
J Clin Virol. 2017 Nov;96:84-88
pubmed: 29031156
J Clin Microbiol. 2003 May;41(5):2153-5
pubmed: 12734265
Lancet HIV. 2016 Sep;3(9):e441-e448
pubmed: 27562745
J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):22190
pubmed: 28872270
Int J Infect Dis. 2019 Jun;83:86-87
pubmed: 30986542
AIDS. 2009 Jun 19;23(10):1255-9
pubmed: 19455017
BMC Infect Dis. 2009 Feb 18;9:19
pubmed: 19226452
J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21755
pubmed: 28872271
AIDS Res Hum Retroviruses. 2017 Nov;33(11):1077-1079
pubmed: 28670913
J Infect Dis. 2020 Oct 13;222(10):1660-1669
pubmed: 32433757
PLoS One. 2020 Aug 13;15(8):e0237239
pubmed: 32790692
J Clin Microbiol. 2003 Aug;41(8):3868-9
pubmed: 12904405
J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21780
pubmed: 28872272
BMC Infect Dis. 2013 Feb 22;13:96
pubmed: 23432847
BMC Infect Dis. 2016 Mar 05;16:113
pubmed: 26945861
PLoS One. 2019 Dec 20;14(12):e0226391
pubmed: 31860677